ADMA R&D to Revenue
Adma Biologics Inc · R&D to Revenue
ADMA R&D to Revenue
Latest reported4.83%period ending
ADMA Quarterly R&D/Revenue (0.00% → 4.83%)
Latest values, visible window
High-resolution chart · PNG
ADMA r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 4.8346% | |
| 2.2683% | |
| 0.9888% | |
| 1.1384% | |
| 0.8452% | |
| 0.7195% | |
| 0.3326% | |
| 0.3438% | |
| 0.5224% | |
| 0.5496% | |
| 0.6028% | |
| 0.8859% | |
| 2.3335% | |
| 1.5023% | |
| 2.1494% | |
| 2.5358% | |
| 2.576% | |
| 2.1445% | |
| 2.7631% | |
| 3.726% | |
| 6.4993% | |
| 6.1541% | |
| 7.2618% | |
| 16.6245% | |
| 21.27% | |
| 14.988% | |
| 3.8616% | |
| 6.8038% | |
| 7.8798% | |
| 24.6737% | |
| -3.5726% | |
| 31.138% | |
| 31.6135% | |
| 31.7097% | |
| 15.5328% | |
| 38.3572% | |
| 39.9602% | |
| 45.3703% | |
| 17.5317% | |
| 57.0913% | |
| 149.6599% | |
| 95.4718% | |
| 79.485% | |
| 113.9867% | |
| 114.9608% | |
| 93.2551% | |
| 128.9495% | |
| 108.5655% | |
| 118.902% | |
| 277.494% | |
| 697.1549% | |
| 127.2408% | |
| 466.903% | |
| 185.0825% | |
| 242.3057% | |
| 538.5602% | |
| 77.6519% | |
| 1,859.5455% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |